A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung Cancer
The postoperative survival of early-stage non-small-cell lung cancer (NSCLC) patients remains unsatisfactory. In this review, we examined the relevant literature to ascertain the prognostic effect of related indicators on early-stage NSCLC. The prognostic effects of the epidermal growth factor recep...
Main Authors: | Weibo Cao, Quanying Tang, Jingtong Zeng, Xin Jin, Lingling Zu, Song Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/18/4561 |
Similar Items
-
Lobectomy versus sublobar resection for stage I (T1‐T2aN0M0) small cell lung cancer: A SEER population‐based propensity score matching analysis
by: Ning Zhou, et al.
Published: (2023-04-01) -
Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
by: Zoltan Lohinai, et al.
Published: (2019-07-01) -
Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers
by: Xabier Mielgo-Rubio, et al.
Published: (2020-11-01) -
Small Cell Lung Cancer and TNM Staging
by: Ke-Neng CHEN
Published: (2016-06-01) -
Clinical significance of preoperative neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio in the prognosis of resected early‐stage patients with non‐small cell lung cancer: A meta‐analysis
by: Weibo Cao, et al.
Published: (2023-03-01)